secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2021-07-22T23:59:59+00:00
Accession:  0001654954-21-008125
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VistaGen Therapeutics appoints Maggie FitzPatrick to board, replacing retiring director Brian Underdown
--------------------------------------------------------------------------------

- Dr. Brian J. Underdown retired from VistaGen's board and all committees, effective July 21, 2021, with no disagreement.
- Maggie FitzPatrick appointed as independent director; she is a former chief corporate affairs officer at Exelon and J&J.
- Mary L. Rotunno appointed Chair of Corporate Governance and Nominating Committee and member of Audit Committee.
- Jerry B. Gin appointed Chair of Compensation Committee; FitzPatrick also named to Corporate Governance and Nominating Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000165495421008125/0001654954-21-008125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000165495421008125/vtgn8k_july212021.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-008125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer